Home
Company News
Publications
Posters
EN
EN
CN
Company News
First Patient Dosing of RG002 (C3 targeting siRNA) in Health Volunteers
2024-10-23
siRNA Biotech Rigerna Therapeutics Secured over USD$30m Initial Financing with Aspirations to Create Therapies for Kidney Patients
2024-10-01
Dr. Huang Yuanyu Among the List of Top 2% Leading Scientists Globally for 5 Consecutive Years
2024-09-25
Rigerna has Achieved Milestones in Extra-hepatic siRNA Delivery
2024-05-01